AIDS and Behavior

, Volume 13, Issue 1, pp 10–22

Adherence to Antiretroviral Medication Regimens: A Test of a Psychosocial Model

  • Colleen DiIorio
  • Frances McCarty
  • Lara DePadilla
  • Ken Resnicow
  • Marcia McDonnell Holstad
  • Katherine Yeager
  • Sanjay M. Sharma
  • Donald E. Morisky
  • Brita Lundberg
Original Research

Abstract

Objective The primary aim of this study was to test a psychosocial model of medication adherence among people taking antiretroviral medications. This model was based primarily on social cognitive theory and included personal (self-efficacy, outcome expectancy, stigma, depression, and spirituality), social (social support, difficult life circumstances), and provider (patient satisfaction and decision-making) variables. Design The data for this analysis were obtained from the parent study, which was a randomized controlled trial (Get Busy Living) designed to evaluate an intervention to foster medication adherence. Factor analysis was used to develop the constructs for the model, and structural equation modeling was used to test the model. Only baseline data were used in this cross sectional analysis. Methods Participants were recruited from a HIV/AIDS clinic in Atlanta, GA. Prior to group assignment, participants were asked to complete a questionnaire that included assessment of the study variables. Results A total of 236 participants were included in the analysis. The mean age of the participants was 41 years; the majority were male, and most were African-American. In the final model, self-efficacy and depression demonstrated direct associations with adherence; whereas stigma, patient satisfaction, and social support were indirectly related to adherence through their association with either self-efficacy or depression. Conclusion These findings provide evidence to reinforce the belief that medication-taking behaviors are affected by a complex set of interactions among psychosocial variables and provide direction for adherence interventions.

Keywords

AIDS Medication adherence Antiretroviral medication 

References

  1. Airlie, J., Baker, G. A., Smith, S. J., & Young, C. A. (2001). Measuring the impact of multiple sclerosis on psychosocial functioning: The development of a new self-efficacy scale. Clinical Rehabilitation, 15, 259–265.PubMedCrossRefGoogle Scholar
  2. Altice, F. L., Mostashari, F., & Friedland, G. H. (2001). Trust and the acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 28, 47–58.PubMedGoogle Scholar
  3. Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., Vecchiet, J., D’Arminio Monforte, A., Wu, A. W., Antinori, A., & AdICoNA Study Group (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes, 31, S3:s123–s127.Google Scholar
  4. Ammassari, A., Antinori, A., Aloisi, M., Trotta, M., Murri, R., Bartoli, L., D’Arminio Monforte, A., Wu, A. W., & Starace, F. (2004). Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics, 45, 394–402.PubMedCrossRefGoogle Scholar
  5. Anderson, L. A., DeVellis, R. F., Boyles, B., & Feussner, J. R. (1989). Patients’ perceptions of their clinical interactions: Development of the multidimensional desire for control scales. Health Education Research, 4, 383–397.CrossRefGoogle Scholar
  6. Arnstein, P., Caudill, M., Mandle, C. L., Norris, A., & Beasley, R. (1999). Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain, 80, 483–491.PubMedCrossRefGoogle Scholar
  7. Bandura, A. (1997). Self-efficacy: The exercise of control. New York: W. H. Freeman and Company.Google Scholar
  8. Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., & Moss, A. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1181–1183.PubMedCrossRefGoogle Scholar
  9. Barnard, K. E. (1994). Difficult life circumstances scale. Seattle: NCAST Publications.Google Scholar
  10. Bartlett, J. A., DeMasi, R., Quinn, J., Moxham, C., & Rousseau, F. (2001). Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS, 15, 1369–1377.PubMedCrossRefGoogle Scholar
  11. Brandt, P. A., & Weinert, C. (1981). The PRQ-A social support measure. Nursing Research, 30, 227–230.CrossRefGoogle Scholar
  12. Browne, M. W., & Cudeck, R. (1993). Alternative ways of assessing model fit. In K. A. Bollen & J. S. Long (Eds.), Testing structural equation models (pp. 136–162). Newbury Park: Sage.Google Scholar
  13. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124–133.PubMedCrossRefGoogle Scholar
  14. Chesney, M. A., Chambers, D. B., Ickovics, J. R., Gifford, A. L., Neidig, J., Zwickl, B., & Wu, A. W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS CARE, 12, 255–267.PubMedCrossRefGoogle Scholar
  15. Coleman, C. (2004). The contribution of religious and existential well-being to depression among African American heterosexuals with HIV infection. Issues in Mental Health Nursing, 25, 103–110.PubMedCrossRefGoogle Scholar
  16. DiIorio, C., Shafer, P. O., Letz, R., Henry, T. R., Schomer, D. L., & Yeager, K. A. (2004). Project EASE: A study to test a psychosocial model of epilepsy medication management. Epilepsy and Behavior, 5, 926–936.PubMedCrossRefGoogle Scholar
  17. DiIorio, C., McCarty, F., Resnicow, K., Holstad, M. M., Soet, J., Yeager, K., Sharma, S. M., Morisky, D. E., & Lundberg, B. (2007, in press). Using motivational interviewing to promote adherence to antiretroviral medications: A randomized controlled study. AIDS Cure. Google Scholar
  18. DiMatteo, M. R. (2003). Future directions in research on consumer-provider communication and adherence to cancer prevention and treatment. Patient Education and Counseling, 50, 23–26.PubMedGoogle Scholar
  19. Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Education and Counseling, 46, 93–108.PubMedCrossRefGoogle Scholar
  20. Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients in multidrug antiretroviral regimens. JAIDS Journal of Acquired Immune Deficiency Syndromes, 23, 386–395.Google Scholar
  21. Godin, G., Cote, J., Naccache, H., Lambert, L. D., & Trottier, S. (2005). Prediction of adherence to antiretroviral therapy: A one-year longitudinal study. AIDS CARE, 17, 493–504.PubMedCrossRefGoogle Scholar
  22. Goffman, E. (1963). Stigma: Notes on the management of spoiled identity. Englewood Cliffs: Prentice-Hall, Inc.Google Scholar
  23. Goldstein, R. B., Johnson, M. O., Rotheram-Borus, M. J., Kirshenbaum, S. B., Pinto, R. M., Kittel, L., Pequegnat, W., Mickalian, M. A., Weinhardt, L. S., Kelly, J. A., Lightfoot, M., & NIMH Healthy Living Project Team (2005). Psychological distress, substance use, and adjustment among parents living with HIV. Journal of the American Board of Family Practice, 18, 362–373.PubMedCrossRefGoogle Scholar
  24. Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J., Kaplan, A. H., & Wenger, N. S. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756–765.PubMedCrossRefGoogle Scholar
  25. Gonzalez, J. S., Penedo, F. J., Antoni, M. H., Duran, R. E., Fernandez, M. I., McPherson-Baker, S., Ironson, G., Klimas, N. G., Fletcher, M. A., & Schneiderman, N. (2004). Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology, 23, 413–418.PubMedCrossRefGoogle Scholar
  26. Heisler, M., Bouknight, R., Hayward, R. A, Smith, D. M., & Kerr, E. A. (2002). The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. Journal of General Internal Medicine, 17, 243–251.PubMedCrossRefGoogle Scholar
  27. Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., Stone, V. E., Smith, D. K., Schoenbaum, E. E., & HER Study Group. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16, 2175–2182.PubMedCrossRefGoogle Scholar
  28. Ickovics, J. R., Cameron, A., Zackin, R., Bassett, R., Chesney, M., Johnson, V. A., Kuritzkes, D. R., & Adult AIDS Clinical Trials Group 370 Protocol Team (2002). Consequences and determinants of adherence to antiretroviral medication: Results from Adult AIDS Clinical Trials Group Protocol 370. Antiviral Therapy, 7, 185–193.Google Scholar
  29. Ironson, G., Solomon, G. F., Balbin, E. G., O’Cleirigh, C., George, A., Kumar, M., Larson, D., & Woods, T. E. (2002). The Ironson–Woods Spirituality/Religiousness Index is associated with long survival, health behaviors, less distress, and low cortisol in people with HIV/AIDS. Annals of Behavioral Medicine, 24, 34–48.PubMedCrossRefGoogle Scholar
  30. Jöreskog, K., & Sorbom, D. (1984). LISREL-VI user’s guide (3rd ed.). Mooresville: Scientific Software.Google Scholar
  31. Kleeberger, C. A., Buechner, J., Palella, F., Detels, R., Riddler, S., Godfrey, R., & Jaconson, L. P. (2004). Changes in adherence to highly active antiretroviral therapy medications in the multicenter AIDS cohort study. AIDS, 18, 683–688.PubMedCrossRefGoogle Scholar
  32. Latkin, C. A., Tobin, K. E., & Gilbert, S. H. (2002). Shun or support: The role of religious behaviors and HIV-related health care among drug users in Baltimore, Maryland. AIDS and Behavior, 6, 321–329.CrossRefGoogle Scholar
  33. Lee, R. S., Kochman, A., & Sikkema, K. (2002). Internalized stigma among people living with HIV-AIDS. AIDS and Behavior, 6, 309–319.CrossRefGoogle Scholar
  34. MacCallum, R. C. (1986). Specification searches in covariance structure modeling. Psychological Bulletin, 100, 107–120.CrossRefGoogle Scholar
  35. Machtinger, E., & Bangsberg, D. R. (2005). Adherence to HIV antiretroviral therapy. In L. Peiperl & P. A. Volberding (Eds.), HIV insite knowledge base [textbook on-line]. Available at http://hivinsite.ucsf.edu/InSite?page=kb-03-02-09
  36. Marsh, H., & Hocevar, D. (1985). Application of confirmatory factor analysis to the study of self-concept: First and higher order factor models and their invariance across groups. Psychological Bulletin, 97, 562–582.CrossRefGoogle Scholar
  37. Marshall, G., Hays, R., Sherbourne, C., & Wells, K. (1993). The structure of patient satisfaction with outpatient medical care. Psychological Assessment, 5, 477–483.CrossRefGoogle Scholar
  38. Mazure, C. M., & Maciejewski, P. K. (2003). A model of risk for major depression: Effects of life stress and cognitive style vary by age. Depression and Anxiety, 17, 26–33.PubMedCrossRefGoogle Scholar
  39. Mostashari, F., Riley, E., Selwyn, P. A., & Altice, F. L. (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 18, 341–348.Google Scholar
  40. Murphy, D. A., Marelich, W. D., Hoffman, D., & Steers, W. N. (2004). Predictors of antiretroviral adherence. AIDS CARE, 16, 471–484.PubMedCrossRefGoogle Scholar
  41. Ong, A. D., & Walsh, D. A. (2001). Nicotine dependence, depression, and the moderating role of goal cognitions. Psychology of Addictive Behaviors, 15, 252–254.PubMedCrossRefGoogle Scholar
  42. Paloutzian, R. F., & Ellison, C. W. (1982). Loneliness, spiritual well-being and quality of life. In L. A. Peplau & D. Perlman (Eds.), Loneliness: A sourcebook of current theory, research and therapy (pp 224–237). New York: Wiley Interscience.Google Scholar
  43. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMedGoogle Scholar
  44. Pequegnat, W., Bauman, L. J., Bray, J. H., DiClemente, R., DiIorio, C., Hoppe, S. K., Jemmott, L. S., Krauss, B., Miles, M., Paikoff, R., Rapkin, B., Rotheram-Borus, M. J., Szapocznik, J. (2001). Measurement of the role of families in prevention and adaptation to HIV/AIDS. AIDS and Behavior, 5, 1–19.CrossRefGoogle Scholar
  45. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.CrossRefGoogle Scholar
  46. Schneider, J., Kaplan, S. H., Greenfield, S., Wenjun, L., & Wilson, I. B. (2004). Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. Journal of General Internal Medicine, 19, 1096–1103.PubMedCrossRefGoogle Scholar
  47. Simoni, J. M., Frick, P. A., Lockhart, D., & Liebovitz, D. (2002). Mediators of social support and antiretroviral adherence among an indigent population in New York City. AIDS Patient Care and STDS, 16, 431–439.PubMedCrossRefGoogle Scholar
  48. Sledjeski, E. M., Delahanty, D. L., & Bogart, L. M. (2005). Incidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4+ counts in people living with HIV. AIDS Patient Care and STDs, 19, 728–736.PubMedCrossRefGoogle Scholar
  49. Sowell, R., Moneyham, L., Hennessy, M., Guillory, J., Demi, A., & Seals, B. (2000). Spiritual activities as a resistance resource for women with human immunodeficiency virus. Nursing Research, 49, 73–82.PubMedCrossRefGoogle Scholar
  50. Sterk, C., Klein, H., & Elifson, K.W. (2003). Perceived condom use self-efficacy among at-risk women. AIDS and Behavior, 7, 175–182.PubMedCrossRefGoogle Scholar
  51. Tuldra, A., Ferrer, M. J., Fumaz, C. R., Bayes, R., Paredes, R., Burger, D. M, & Clotet, B., (1999). Monitoring adherence to HIV Therapy. Archives of Internal Medicine, 159, 1376–1377.PubMedCrossRefGoogle Scholar
  52. Viswanathan, H., Anderson, R., & Thomas, J., 3rd. (2005). Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence. AIDS Patient Care and STDs, 19, 306–316.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Colleen DiIorio
    • 1
  • Frances McCarty
    • 2
  • Lara DePadilla
    • 1
  • Ken Resnicow
    • 3
  • Marcia McDonnell Holstad
    • 4
  • Katherine Yeager
    • 2
  • Sanjay M. Sharma
    • 5
  • Donald E. Morisky
    • 6
  • Brita Lundberg
    • 7
  1. 1.Department of Behavioral Sciences and Health Education, Rollins School of Public HealthEmory UniversityAtlantaUSA
  2. 2.Department of Behavioral Sciences and Health Education, Rollins School of Public HealthEmory UniversityAtlantaUSA
  3. 3.Health Behavior & Health Education School of Public HealthUniversity of MichiganAnn ArborUSA
  4. 4.Nell Hodgson Woodruff School of NursingEmory UniversityAtlantaUSA
  5. 5.Department of Psychiatry and Behavioral SciencesEmory University School of MedicineAtlantaUSA
  6. 6.Department of Community Health SciencesUCLA School of Public HealthLos AngelesUSA
  7. 7.Newton CentreUSA

Personalised recommendations